Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats
Hariom Kumar, Bhupesh Sharma
Brain Research (2015) Vol. 1630, pp. 83-97
Closed Access | Times Cited: 95

Showing 26-50 of 95 citing articles:

5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats
Kazuya Matsuo, Yasushi Yabuki, Kohji Fukunaga
Neuropharmacology (2020) Vol. 168, pp. 107975-107975
Closed Access | Times Cited: 44
Research Progress in Vitamin A and Autism Spectrum Disorder
Zhonghui Liu, Jingyu Wang, Qu Xu, et al.
Behavioural Neurology (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 37
Kefir ameliorates specific microbiota-gut-brain axis impairments in a mouse model relevant to autism spectrum disorder
Marcel van de Wouw, Calum J. Walsh, Giulia M.D. Vigano, et al.
Brain Behavior and Immunity (2021) Vol. 97, pp. 119-134
Open Access | Times Cited: 33
The hygienic insecticide dimefluthrin induced neurodevelopmental deficits and behavioral disorders in zebrafish (Danio rerio) larvae
Ruirui Li, Wenping Xu, Qiao‐Qiao Li, et al.
Environmental Research (2025) Vol. 268, pp. 120777-120777
Closed Access
Emerging autism and Fragile X syndrome treatments
Michael David Parkhill, Natalina Salmaso, Amedeo D’Angiulli, et al.
Trends in Pharmacological Sciences (2025)
Closed Access
Autism Spectrum Disorder, Oral Implications, and Oral Microbiota
Emiliana D’Angelo, Fausto Fiori, Giuseppe Andrea Ferraro, et al.
Children (2025) Vol. 12, Iss. 3, pp. 368-368
Open Access
Sex-Specific Behavioral Features of the Prenatal Valproic Acid Rat Model of Autism Spectrum Disorder
Patience Mulalo Mamali, Christine Dignon, Ayanda Ngwenya, et al.
Brain Sciences (2025) Vol. 15, Iss. 4, pp. 388-388
Open Access
Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models
Hsiao‐Ying Kuo, Fu‐Chin Liu
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 46
Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats
Roohi Mirza, Bhupesh Sharma
Life Sciences (2018) Vol. 214, pp. 106-117
Closed Access | Times Cited: 44
Gut-to-Brain Axis in Autism Spectrum Disorders
Aletta D. Kraneveld, Kirsten Szklany, Caroline G. M. de Theije, et al.
International review of neurobiology (2016), pp. 263-287
Closed Access | Times Cited: 41
Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173663-173663
Closed Access | Times Cited: 36
Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
Autism Research (2021) Vol. 14, Iss. 11, pp. 2270-2286
Closed Access | Times Cited: 31
Animal models for autism in 2017 and the consequential implications to drug discovery
Kathryn K. Chadman
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 12, pp. 1187-1194
Closed Access | Times Cited: 35
Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism
Mauro Mozael Hirsch, Iohanna Deckmann, Júlio Santos‐Terra, et al.
Neuropharmacology (2020) Vol. 167, pp. 107930-107930
Open Access | Times Cited: 31
Serum claudin-5, claudin-11, occludin, vinculin, paxillin, and beta-catenin levels in preschool children with autism spectrum disorder
Ayhan Bi̇lgi̇ç, Hurşit Ferahkaya, Hülya Karagöz, et al.
Nordic Journal of Psychiatry (2023) Vol. 77, Iss. 5, pp. 506-511
Closed Access | Times Cited: 10
Microglia and Autism Spectrum Disorder: Overview of Current Evidence and Novel Immunomodulatory Treatment Options
Jung Won Kim, Ji Yeon Hong, Seung Min Bae
Clinical Psychopharmacology and Neuroscience (2018) Vol. 16, Iss. 3, pp. 246-252
Open Access | Times Cited: 29
Resveratrol prevents brain edema, blood–brain barrier permeability, and altered aquaporin profile in autism animal model
Iohanna Deckmann, Júlio Santos‐Terra, Mellanie Fontes‐Dutra, et al.
International Journal of Developmental Neuroscience (2021) Vol. 81, Iss. 7, pp. 579-604
Open Access | Times Cited: 22
Increasing Endocannabinoid Tone Alters Anxiety-Like and Stress Coping Behaviour in Female Rats Prenatally Exposed to Valproic Acid
Aoife M. Thornton, Rachel M. Humphrey, Daniel M. Kerr, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3720-3720
Open Access | Times Cited: 21
Critical Evaluation of Valproic Acid-Induced Rodent Models of Autism: Current and Future Perspectives
Sweety Mehra, Aitizaz Ul Ahsan, Era Seth, et al.
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 6, pp. 1259-1273
Closed Access | Times Cited: 14
Blood–Brain Barrier Integrity Is Perturbed in a Mecp2-Null Mouse Model of Rett Syndrome
Giuseppe Pepe, Salvatore Fioriniello, Federico Marracino, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 606-606
Open Access | Times Cited: 8
Microglia as possible therapeutic targets for autism spectrum disorders
Megumi Andoh, Yuji Ikegaya, Ryuta Koyama
Progress in molecular biology and translational science (2019), pp. 223-245
Closed Access | Times Cited: 25
Altered Blood Brain Barrier Permeability and Oxidative Stress in Cntnap2 Knockout Rat Model
Idil Memis, Rahul Mittal, Emily Furar, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 10, pp. 2725-2725
Open Access | Times Cited: 13
Minocycline Acts as a Neuroprotective Agent Against Tramadol-Induced Neurodegeneration: Behavioral and Molecular Evidence
Mina Gholami, Zahra Ghelichkhani, Reza Aghakhani, et al.
International Journal of Preventive Medicine (2024) Vol. 15
Open Access | Times Cited: 2
Postnatal baicalin ameliorates behavioral and neurochemical alterations in valproic acid-induced rodent model of autism: The possible implication of sirtuin-1/mitofusin-2/ Bcl-2 pathway
Rasha Osama El‐Esawy, Omnia Safwat El‐Deeb, Amira Kamel Eltokhy, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112960-112960
Open Access | Times Cited: 12
Under or Absent Reporting of Light Stimuli in Testing of Anxiety-Like Behaviors in Rodents: The Need for Standardization
Lorenz S. Neuwirth, Michael T. Verrengia, Zachary I. Harikinish-Murrary, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 11

Scroll to top